Drug Information

Drug General Information
Drug ID
D02SNO
Former ID
DNC011817
Drug Name
2-Phenyl-3-(1-phenyl-ethoxy)-piperidine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [551332]
Structure
Download
2D MOL

3D MOL
Formula
C19H23NO
Canonical SMILES
CC(C1=CC=CC=C1)OC2CCCNC2C3=CC=CC=C3
InChI
1S/C19H23NO/c1-15(16-9-4-2-5-10-16)21-18-13-8-14-20-19(18)17-11-6-3-7-12-17/h2-7,9-12,15,18-20H,8,13-14H2,1H3/t15-,18+,19+/m1/s1
InChIKey
FFKDZHIKRMLWQT-MNEFBYGVSA-N
PubChem Compound ID
44331715
Target and Pathway
Target(s) Substance-P receptor Target Info Inhibitor [551332]
KEGG Pathway Calcium signaling pathway
Neuroactive ligand-receptor interaction
Measles
PANTHER Pathway CCKR signaling map ST
Reactome G alpha (q) signalling events
WikiPathways SIDS Susceptibility Pathways
Gastrin-CREB signalling pathway via PKC and MAPK
Spinal Cord Injury
Peptide GPCRs
GPCR ligand binding
GPCR downstream signaling
References
Ref 5513323-Benzyloxy-2-phenylpiperidine NK1 antagonists: the influence of alpha methyl substitution, Bioorg. Med. Chem. Lett. 7(23):2959-2962 (1997).
Ref 5513323-Benzyloxy-2-phenylpiperidine NK1 antagonists: the influence of alpha methyl substitution, Bioorg. Med. Chem. Lett. 7(23):2959-2962 (1997).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.